Skip to main content

TRANSCEND CAPITAL ADVISORS, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1776082 MADISON, NJ

Position in TEVA

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$417,367
+$47,373 QoQ
Shares Held
12,319
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#414
of 673 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TRANSCEND CAPITAL ADVISORS, LLC holds $1,617,958 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (25.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 TEVA
Teva Pharmaceutical Industries Ltd
This page
12,319 $417,367

All Filings in TEVA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $417,367 12,319
2026-03-31 $369,994 12,284
2025-12-31 $382,884 12,268
2025-09-30 $254,823 12,615
2025-06-30 $229,477 13,692
2025-03-31 $195,491 12,719
2024-12-31 $281,098 12,754
2024-09-30 $229,250 12,722
2024-06-30 $205,497 12,646
2024-03-31 $175,669 12,450
2023-12-31 $130,948 12,543
2023-09-30 $112,638 11,043
2023-06-30 $83,153 11,043
2023-03-31 $97,730 11,043
2022-12-31 $118,040 12,943
2022-09-30 $103,699 12,850
2022-06-30 $96,632 12,850
2022-03-31 $120,661 12,850
2021-12-31 $87,709 10,950
2021-09-30 $108,114 11,100
2021-06-30 $115,305 11,647
2021-03-31 $128,094 11,100
2020-12-31 $107,115 11,100
2020-09-30 $100,011 11,100
2020-03-31 $98,331 10,950